Navigation Links
Alison Martin, MD and Robert W. Malone, MD Join Beardsworth
Date:6/25/2010

FLEMINGTON, N.J., June 24 /PRNewswire/ -- Beardsworth Consulting Group, Inc. announces the appointments of Alison Martin, M.D. as the company's Scientific Advisor, Oncology and Robert W. Malone, M.D. as the company's Medical Director, Vaccines.

Dr. Alison Martin is one of oncology's respected research leaders with over 20 years of clinical research experience.  She joins Beardsworth from the National Cancer Institute (NCI) where she was most recently Head of Genitourinary Cancers and Melanoma Therapeutics in the Clinical Investigations Branch of the Cancer Therapy Evaluation Program (CTEP).  Dr. Martin was scientific co-chair along with Dr. Meenhard Herlyn of the 2007 NCI-Community-Oriented Strategic Action Plan for Melanoma Research.  She has served as liaison to three of NCI's cooperative groups and been a senior investigator in the Investigational Drug Branch of CTEP.  In addition to experience at NCI, Dr. Martin was a team leader in the Office of Oncology Drug Products at the U.S. Food and Drug Administration and has experience working with the biotechnology and pharmaceutical industries.

Dr. Robert Malone has extensive experience in viral and recombinant vaccines, biodefense, gene delivery and transfer, immunology, tissue and cell culture, and DNA vaccination in both the commercial and government market sectors.  An internationally recognized scientist, Dr. Malone is known as one of the original inventors of "DNA Vaccination" holding numerous fundamental domestic & foreign patents in the fields of gene delivery, delivery formulations, and vaccines.  His background includes over 25 years of experience in academia and industry, including both founding and working with a wide range of pharmaceutical and biotech companies.  He has experience in federal contracting, working with NGO's in health related research and development as well as relationships with CDC, DOD and HHS.  Dr. Malone is involved with 15 issued patents, has numerous publications and two book chapters in this field, and serves as editor-in-chief of the Journal of Immune Based Therapies and Vaccines.

"We are honored and excited to have Alison and Robert join the Beardsworth team," said Michael J. O'Brien, President and CEO, Beardsworth.  He added, "the increasing demands of Oncology and Vaccine research, individually and together, place Beardsworth in an attractive position given our many years of experience in these two areas.  Alison and Robert will provide valuable expertise and vision to the expanding clinical research needs of our growing client base."

As members of Beardsworth's team, Drs. Martin and Malone join other noted industry experts whose collective strategic scope and in-depth knowledge support Beardsworth's mission of delivering superior quality clinical services, on time and on budget.

Headquartered in Flemington, New Jersey, Beardsworth is a privately held contract research organization delivering research and business solutions for clinical research programs since 1986.  Focused on complicated trials in complex therapeutic areas, Beardsworth's clinical team expertise, advanced technology platform, and "Investigator Express" process provide clients with a patient-centric approach to study management, patient recruitment and cost-effective solutions.  Beardsworth is a WBENC-certified, woman-owned business and registrant with CCR.


'/>"/>
SOURCE Beardsworth Consulting Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. First ASMS Hites Award for Outstanding Research Publication Presented to Prof. Alison Ashcroft for Her Use of Waters Synapt HDMS System to Explore Protein Complexes
2. Northwest Biotherapeutics Announces Appointment of Robert A. Farmer to the Board of Directors
3. Advanced Cell Technologys Chief Scientific Officer, Robert Lanza, Opening Plenary Speaker at the 3rd International Conference on Cell Therapy
4. Organovo Appoints Robert Baltera to Board
5. Soligenix Appoints Robert J. Rubin, MD, to its Board of Directors
6. Dr. Robert Lanza Featured on Michio Kakus Explorations in Science
7. Accuray Incorporated to Present at Robert Baird 2009 Healthcare Conference
8. Kendle to Present at Robert Baird 2009 Health Care Conference
9. PAREXEL International to Present at Robert Baird 2009 Healthcare Conference
10. Affitech Appoints Dr Robert Burns as CEO and Dr Alexander Duncan as SVP Research & Development
11. Robert Zanotti, MD, Is First Lorain County, Ohio Orthopedic Surgeon to Perform Reverse Total Shoulder Replacement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... Parallel ... clinical trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module ... circle with the physician and clinical trial team. , Using the CONSULT module, patients ...
(Date:6/27/2016)... BOSTON , June 27, 2016   Ginkgo ... biology to industrial engineering, was today awarded as ... a selection of the world,s most innovative companies. ... at scale for the real world in the ... organism engineers work directly with customers including Fortune ...
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal ... Their findings are the subject of a new article on the Surviving Mesothelioma website. ... the blood, lung fluid or tissue of mesothelioma patients that can help point doctors ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
Breaking Biology Technology:
(Date:5/12/2016)... DALLAS , May 12, 2016 ... has just published the overview results from the Q1 ... of the recent wave was consumers, receptivity to a ... wearables data with a health insurance company. ... choose to share," says Michael LaColla , CEO ...
(Date:4/28/2016)... India , April 28, 2016 ... Infosys (NYSE: INFY ), and Samsung SDS, a ... that will provide end customers with a more secure, ... services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... services, but it also plays a fundamental part in enabling ...
(Date:4/26/2016)... DUBLIN , April 27, 2016 ... of the  "Global Multi-modal Biometrics Market 2016-2020"  report ... ) , The analysts forecast ... a CAGR of 15.49% during the period 2016-2020.  ... a number of sectors such as the healthcare, ...
Breaking Biology News(10 mins):